{
  "meta": {
    "title": "212_Medicine_Aiims_2018",
    "url": "https://brainandscalpel.vercel.app/212-medicine-aiims-2018-0eb9985f.html",
    "scrapedAt": "2025-11-30T12:56:57.891Z"
  },
  "questions": [
    {
      "text": "An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next?",
      "choices": [
        {
          "id": 1,
          "text": "Cytarabine"
        },
        {
          "id": 2,
          "text": "Dexamethasone"
        },
        {
          "id": 3,
          "text": "Doxorubicin"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario describes a patient of <strong>APL </strong>(acute promyelocytic leukemia) developing <strong>fever, tachypnea</strong>, and<strong> pulmonary infiltrates</strong> while <strong>on medical treatment</strong>. This is suggestive of <strong>APL differentiation syndrome</strong>, an <strong>adverse effect </strong>of <strong>all-trans-retinoic acid (ATRA)</strong>. The management involves glucocorticoids like <strong>dexamethasone</strong>.&nbsp;</p>\n<p>Along with <strong>glucocorticoids</strong>, the other management of APL differentiation syndrome includes <strong>chemotherapy </strong>for <strong>cytoreduction </strong>and <strong>supportive measures</strong>. In <strong>severe </strong>cases,<strong> temporary discontinuation of ATRA</strong> is necessary.</p>\n<p><strong>ATRA</strong> is an oral drug that induces the <strong>differentiation</strong> of leukemic cells bearing the <strong>t(15;17) </strong>chromosomal translocation. While ATRA reduces the incidence of <strong>DIC</strong> associated with <strong>cytarabine</strong> and <strong>daunorubicin</strong> used earlier in APL, it can cause <strong>APL differentiation syndrome</strong> due to the <strong>adhesion </strong>of differentiated neoplastic cells to the <strong>pulmonary vasculature endothelium</strong>.</p>\n<p>In <strong>low-risk APL </strong>patients with a low leukocyte count at presentation, a combination of <strong>ATRA </strong>and <strong>arsenic trioxide (ATO)</strong> has been found to be superior and is the current standard of care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1143",
      "difficulty": "easy"
    },
    {
      "text": "A 50-year-old man was brought to the emergency in an unconscious state. He had a fever for the past two days and is a known case of severe COPD. His ECG is given below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Ventricular tachycardia"
        },
        {
          "id": 2,
          "text": "Multifocal atrial tachycardia"
        },
        {
          "id": 3,
          "text": "Atrial fibrillation"
        },
        {
          "id": 4,
          "text": "Atrial tachycardia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of chronic pulmonary disease and the ECG showing different p wave morphologies are suggestive of <strong>multifocal atrial tachycardia</strong>.</p>\n<p><strong>Multifocal atrial tachycardia </strong>(MAT) occurs due to impulses arising from <strong>multiple abnormal foci</strong> in the atria. This leads to supraventricular tachycardia with p waves and QRS complexes of different morphologies. It is usually encountered in patients with <strong>chronic pulmonary disease and acute illness.&nbsp;</strong></p>\n<p>Therapy for MAT is directed at <strong>treating the underlying disease</strong> and correcting any metabolic abnormalities. Calcium-channel blockers and radiofrequency ablation of the AV node are the other treatment modalities.</p>\n<p>The given ECG shows narrow QRS complexes with irregular RR intervals, hence it can be atrial fibrillation or multifocal atrial tachycardia. The next step is to look at the p waves. Multifocal atrial tachycardia (MAT) is characterized by at least<strong> 3 distinct P-wave morphologies</strong> (shown by arrows in the image).&nbsp;Whereas, in atrial fibrillation, there would be no distinct p waves seen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ca1f22af8114d94ba32e0c4cd65fa6bx1280x697.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ad613063d3a9426ca5cce755fc488010.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5295",
      "difficulty": "easy"
    },
    {
      "text": "Infertility in Kartagener’s syndrome is due to which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Oligospermia"
        },
        {
          "id": 2,
          "text": "Asthenospermia"
        },
        {
          "id": 3,
          "text": "Undescended testes"
        },
        {
          "id": 4,
          "text": "Epididymis obstruction"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Kartagener&rsquo;s syndrome</strong> is a type of <strong>primary ciliary dyskinesia</strong> characterized by the classical triad of</p>\n<ul>\n<li>Situs inversus</li>\n<li>Chronic sinusitis</li>\n<li>Bronchiectasis</li>\n</ul>\n<p><strong>Infertility</strong> in Kartagener&rsquo;s syndrome is due to <strong>asthenospermia</strong> (immotile spermatozoa due to impaired sperm flagella function), <strong>not azoospermia</strong> (complete absence of spermatozoa in ejaculate).</p>\n<p><strong>Primary ciliary dyskinesia</strong> (also called immotile cilia syndrome) is an <strong>autosomal recessive disorder affecting ciliary motility</strong>. It occurs due to <strong>ultrastructural defects in the dynein arm</strong> of cilia. This causes the retention of secretions due to a failed mucociliary clearance mechanism. Clinically, this manifests as <strong>chronic sinusitis</strong> and recurrent infections that ultimately lead to <strong>bronchiectasis</strong>. As ciliary function is necessary to ensure proper rotation of the developing organs in the chest and abdomen, its absence will lead to <strong>situs inversus or a partial lateralizing abnormality</strong>. Approximately half of the patients with primary ciliary dyskinesia have Kartagener syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5289",
      "difficulty": "easy"
    },
    {
      "text": "Calculate the GCS Score in an intubated patient, with findings of eye movements to pain and abnormal flexion?",
      "choices": [
        {
          "id": 1,
          "text": "E2VTM4"
        },
        {
          "id": 2,
          "text": "E2VTM3"
        },
        {
          "id": 3,
          "text": "E2V1M3"
        },
        {
          "id": 4,
          "text": "E2VNTM3"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The GCS score is <strong>E2VNTM3.&nbsp;</strong>In this case:</p>\n<ul>\n<li>Eye-opening to pain: E2</li>\n<li>In case of endotracheal intubation or tracheostomy, the verbal component of the score is denoted as 'not testable/NT'. Earlier in intubated patients, the V score was denoted as VT. According to the current update, the V score should be VNT.</li>\n<li>Abnormal flexion: M3</li>\n</ul><hr><h3>Related Pearl: Glasgow Coma Scale (GCS)</h3><div class=\"ng-scope\">\n<p><strong>GCS Score</strong></p>\n<ul>\n<li class=\"ng-binding ng-scope\">13-15 represent mild injury</li>\n<li>9-12 represent moderate injury</li>\n<li>Scores ≤8 represent severe injury </li>\n</ul>\n</div>\n<div class=\"ng-scope\">\n<p><strong>Head Injury Severity: Clinical classification</strong> </p>\n</div>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Eyes Opening</strong></p>\n</td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Spontaneously</td>\n<td>4</td>\n</tr>\n<tr>\n<td>To verbal command</td>\n<td>3</td>\n</tr>\n<tr>\n<td>To painful stimulus</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Do not open</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Verbal response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Normal-oriented conversation</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Confused</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Inappropriate words only</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Sounds only</td>\n<td>2</td>\n</tr>\n<tr>\n<td>No sounds</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Motor Response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Obeys commands</td>\n<td>6</td>\n</tr>\n<tr>\n<td>Localizes to pain</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Withdrawal response to pain</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Abnormal flexion/ Decorticate posturing </td>\n<td>3</td>\n</tr>\n<tr>\n<td>Abnormal extension/ Decerebrate posturing </td>\n<td>2</td>\n</tr>\n<tr>\n<td>No motor response</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Minimum value: </strong>3</p>\n<p><strong>Maximum value:</strong> 15</p>\n<ul>\n<li>GCS, in particular, the <strong>motor score</strong>, is the <strong>best predictor of neurological outcome.</strong></li>\n<li>If an area cannot be assessed, no numerical score is given for that region, and it is considered “non-testable.\" (NT)</li>\n<li>In case of <strong>endotracheal intubation or tracheostomy</strong>, the verbal component of the score is <strong>denoted as NT</strong>.</li>\n<li>A score of  ‘1’ is not recorded in missing components, instead, NT is used</li>\n<li>when a component is Not Testable, a total score is not recorded because the score will be low and this could be confusing to medical colleagues. This may also imply that the patient is more unwell than they actually are.</li>\n</ul>\n<p> </p>\n<div class=\"page\" title=\"Page 163\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>NOTE: </strong></p>\n<p>A new parameter, \"pupil reactivity score\" has been added to GCS, and now, it is referred to as GCS-P.</p>\n</div>\n</div>\n</div>\n<p>P stands for \"Pupils unreactive to light\"</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Pupils unreactive to light</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Both pupils</td>\n<td>2</td>\n</tr>\n<tr>\n<td>One pupil</td>\n<td>1 </td>\n</tr>\n<tr>\n<td>Neither</td>\n<td> 0</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>The pupillary score is subtracted</strong> from the GCS score to give the final value. Therefore, the range of GCS-P is 1–15.</p>\n<p><strong>Note:</strong> The minimum frequency of observations for patients with GCS equal to 15 should be as follows, starting after the initial assessment in the emergency department:</p>\n<ul>\n<li class=\"p-rich_text_section\">Half-hourly for 2 hours,</li>\n<li class=\"p-rich_text_section\">Then 1-hourly for 4 hours,</li>\n<li class=\"p-rich_text_section\">2-hourly thereafter.</li>\n</ul>\n<p>Should the patient with GCS equal to 15 deteriorate at any time after the initial 2-hour period, observations should revert to half-hourly and follow the original frequency schedule.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5292",
      "difficulty": "medium"
    },
    {
      "text": "Two brothers were arguing over a property dispute when the elder of the two complained of chest pain and collapsed and was later declared brought dead by the hospital. His family says he was previously healthy and there was no similar disease in the family members. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Infective cardiomyopathy"
        },
        {
          "id": 2,
          "text": "Takotsubo cardiomyopathy"
        },
        {
          "id": 3,
          "text": "Dilated cardiomyopathy"
        },
        {
          "id": 4,
          "text": "Hypertrophic cardiomyopathy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of sudden heart failure in a previously healthy person under a stressful situation is suggestive of <strong>Takotsubo cardiomyopathy</strong>.</p>\n<p>Takotsubo cardiomyopathy is also called <strong>broken heart syndrome</strong>, apical ballooning syndrome, or stress-induced cardiomyopathy. It is a transient myocardial stunning from <strong>microcirculation spams</strong> due to a <strong>catecholamine surge</strong> during stress. It is usually seen in <strong>middle-aged women</strong>. The patients can present with pulmonary edema, hypotension, and chest pain.</p>\n<div class=\"page\" title=\"Page 2177\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ECHO reveals <strong>apical dilatation</strong> with<strong> basal hypercontraction</strong> of the heart, resembling a <strong>Takotsubo</strong> (pot for catching octopus).  The ECG changes can mimic myocardial infarction but changes extend beyond a particular coronary arterial territory. Coronary angiography, therefore, may be needed to rule out coronary occlusion. (Option B)</p>\n<p>It is a <strong>self-limiting</strong> disorder resolving within days to weeks. The prognosis is generally good.</p>\n<p>The image below shows left ventriculography during systole showing apical ballooning resembling a Takotsubo pot. </p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/410e6c56baec4d9399c51b74c39cb72dx1280x789.JPEG\" alt=\"Explanation Image\"><p><strong>Other options:</strong></p>\n<p>Option A: <strong>Infective cardiomyopathy</strong>: The most common causes of infective myocarditis are <strong>viral infections</strong> and the protozoan <strong>Trypanosoma cruzi</strong>, which is associated with Chagas' disease. Acute viral myocarditis often presents with symptoms and signs of heart failure, although it can also manifest as chest pain and show electrocardiogram (ECG) changes resembling pericarditis or acute myocardial infarction. In Chagas' disease, specific features include abnormalities in the conduction system, particularly dysfunction of the sinus node and AV node, as well as the right bundle branch block.</p>\n<p>Option C:<strong> Dilated cardiomyopathy</strong>: It is the most common cardiomyopathy and is predominantly characterised by <strong>systolic dysfunction</strong>. Though it may present acutely, it <strong>progresses chronically</strong>. The familial form is due to mutations in TTN gene which encode the sarcomeric protein titin. Other etiologocal agents include alcohol, infective myocarditis, doxorubicin, hemochromatosis and sarcoidosis. </p>\n<p>Option D: <strong>Hypertrophic cardiomyopathy</strong>: Hypertrophic cardiomyopathy (HCM) is the <strong>most common genetic</strong> cardiovascular disorder and is a prominent cause of <strong>sudden death</strong> before the age of 35 years. Family history is commonly present, a sarcomere mutation is present in ~50% of patients. Sudden death can be due to polymorphic ventricular tachycardia/fibrillation. Risk factors for sudden death in this disease include young age, nonsustained ventricular tachycardia, failure of blood pressure to increase during <strong>exercise</strong>, recent (within 6 months) syncope, ventricular wall thickness &gt;3 cm, and possibly the severity of LV outflow obstruction.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3498",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is used in the treatment of late cardiovascular syphilis?",
      "choices": [
        {
          "id": 1,
          "text": "Benzathine penicillin 2.4 million units weekly for three weeks"
        },
        {
          "id": 2,
          "text": "Benzathine penicillin 2.4 million units as single dose"
        },
        {
          "id": 3,
          "text": "Benzathine penicillin 12-24 million units for 21 days"
        },
        {
          "id": 4,
          "text": "Tetracycline 2g daily"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Benzathine penicillin 2.4 million</strong> units weekly for <strong>three weeks</strong> is the treatment of <strong>late cardiovascular</strong> syphilis.</p>\n<p>The treatment of syphilis is based on the CDC&rsquo;s 2015 guidelines:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage of Syphilis</strong></td>\n<td><strong>Patients without Penicillin Allergy</strong></td>\n<td><strong>Patients with Confirmed Penicillin Allergy</strong></td>\n</tr>\n<tr>\n<td>Primary, Secondary and early latent</td>\n<td>\n<p>CSF Normal or not examined: Penicillin G benzathine&nbsp; &nbsp; &nbsp;(single dose 2.4mU IM)&nbsp;</p>\n<p>CSF Abnormal: Treat as Neurosyphilis</p>\n</td>\n<td>\n<p>CSF normal or not examined: Tetracycline HCl (500 mg PO qid)</p>\n<p>OR</p>\n<p>Doxycycline(100 mg PO bid) for 2 weeks&nbsp;CSF abnormal: Treat as neurosyphilis</p>\n</td>\n</tr>\n<tr>\n<td>Late latent (or latent of uncertain duration), <strong>Cardiovascular</strong> or benign tertiary</td>\n<td>\n<p>CSF Normal or not examined: Penicillin G benzathine&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.4 mU IM weekly for 3 weeks &nbsp;</p>\n<p>CSF Abnormal: Treat as Neurosyphilis</p>\n</td>\n<td>\n<p>CSF normal and patient not infected with HIV: Tetracycline HCl (500 mg PO qid)</p>\n<p>OR</p>\n<p>Doxycycline (100 mg PO bid) for 4 weeks&nbsp;</p>\n<p>CSF normal and patient infected with HIV: Desensitization and treatment with penicillin if compliance cannot be ensured&nbsp;</p>\n<p>CSF abnormal: Treat as neurosyphilis</p>\n</td>\n</tr>\n<tr>\n<td>Neurosyphilis (asymptomatic or symptomatic)</td>\n<td>\n<p>Aqueous crystalline penicillin G (18-24 mU/d IV),&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; given as 3-4mU q4h or continuous infusion for 10-14 days.</p>\n<p>OR</p>\n<p>Aqueous procaine penicillin G (2.4mU/d IM)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Oral probenecid(500mg qid), both for 10-14 days.</p>\n</td>\n<td>Desensitization and treatment with penicillin</td>\n</tr>\n<tr>\n<td>Syphilis in Pregnancy</td>\n<td>According to stage</td>\n<td>Desensitization and treatment with penicillin&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note:</strong></p>\n<p class=\"p1\">mU is a million units, not milli-units.</p><hr><h3>Related Pearl: Stages of syphilis</h3><p><strong><strong>Primary syphilis:</strong></strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Chancre</strong> - Painless, indurated, usually single. The chancre self heals in 1-4 months.</li>\n<li aria-level=\"1\">Lymphadenopathy - Painless, unilateral or bilateral, shotty and rubbery inguinal nodes</li>\n<li aria-level=\"1\"><strong>Dory flop sign</strong> - As the chancre is too hard to fold, it will flip over once the prepuce is retracted back.</li>\n</ul>\n<p><strong>Secondary syphilis:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/45e19098c36e4e0ba69bdbc3358cbb5fx559x788.JPEG\" alt=\"Pearl Image\"><ul>\n<li aria-level=\"1\">A &amp; B: Generalized non-itchy rash with no vesicles present on the palm and sole. This is the most common lesion.</li>\n<li aria-level=\"1\">C &amp; D:<strong> Condyloma lata</strong>.</li>\n<li aria-level=\"1\">E:<strong> Moth-eaten non-scarring alopecia</strong></li>\n<li aria-level=\"1\">F: Mucous patches are flat erosions on the tongue that can coalesce to form<strong> snail track ulcers.</strong> These are the most infectious lesions.</li>\n<li aria-level=\"1\">G: Pigmentary plaques</li>\n<li aria-level=\"1\">H: Psoriasiform syphilitic lesions</li>\n<li aria-level=\"1\">Generalized diffuse non-tender lymphadenopathy</li>\n</ul>\n<p><strong>Tertiary syphilis:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Gummatous syphilis</strong> are deep punched-out ulcers, with gum-like secretions on the floor</li>\n<li aria-level=\"1\"><strong>Pseudo-chancre redux</strong> is a gumma occurring at the site of a previously healed ulcer&nbsp;&nbsp;</li>\n<li aria-level=\"1\">CVS - Aortitis and aneurysm of the ascending aorta</li>\n<li aria-level=\"1\">CNS - General paresis of the insane and tabes dorsalis&nbsp;</li>\n</ul>\n<p><strong>Latent syphilis</strong> is the period between secondary and tertiary syphilis. In this period the patient is asymptomatic clinically and only serological evidence of the infection is present. It is classified into:</p>\n<ul>\n<li aria-level=\"1\">Early latent syphilis - Within 1 year of infection</li>\n<li aria-level=\"1\">Late latent syphilis - After 1 year of infection</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5294",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs is commonly used for treating community-acquired pneumonia in OPD?",
      "choices": [
        {
          "id": 1,
          "text": "Vancomycin"
        },
        {
          "id": 2,
          "text": "Ceftriaxone"
        },
        {
          "id": 3,
          "text": "Azithromycin"
        },
        {
          "id": 4,
          "text": "Streptomycin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Azithromycin</strong> is the<strong> drug of choice</strong> for <strong>treatment of </strong>community-acquired<strong>&nbsp;</strong>pneumonia&nbsp;<strong>(CAP)</strong> in an <strong>OPD</strong> setup.</p>\n<p><strong>Outpatient management of CAP:&nbsp;</strong></p>\n<p>1. For previously healthy patients who have <strong>not</strong> taken antibiotics within the past 3 months:</p>\n<ul>\n<li>A macrolide &ndash;&nbsp;Azithromycin, 500 mg orally as a first dose and then 250 mg orally daily for 4 days, or 500 mg orally daily for 3 days, <strong>or</strong></li>\n<li>Clarithromycin, 500 mg orally twice a day; or</li>\n<li>Doxycycline 100 mg orally twice a day</li>\n</ul>\n<p>2.&nbsp;For patients with such <strong>comorbid medical conditions</strong> as chronic heart, lung, liver, or kidney disease, diabetes mellitus, alcoholism, malignancy, asplenia, immunosuppressant conditions or use of immunosuppressive drugs or use of antibiotics within the previous 3 months:</p>\n<ul>\n<li>A <strong>respiratory fluoroquinolone</strong> (moxifloxacin, 400 mg orally daily; gemifloxacin, 320 mg orally daily; levofloxacin, 750 mg orally daily) <strong>or</strong></li>\n<li>A <strong>macrolide (as above) plus a beta-lactam</strong> (amoxicillin, 1 g orally three times a day; amoxicillin-clavulanate, 2 g orally twice a day; cefuroxime, 500 mg orally twice a day).</li>\n</ul>\n<p>3.&nbsp;In regions with a <strong>high rate (&gt; 25%) of infection with high level (MIC &ge; 16 mcg/mL) macrolide-resistant</strong> <em>Streptococcus pneumoniae</em>, consider the use of alternative agents listed in (2) for patients with comorbidities.</p>\n<p>Other options: Vancomycin, Ceftriaxone, and Streptomycin are administered parenterally, and hence, not appropriate for outpatient management.</p><hr><h3>Related Pearl: CURB-65 Criteria</h3><p>This is a score to determine the severity of pneumonia.</p>\n<p>The CURB-65 criteria include five variables(1 point for each variable):</p>\n<ul>\n<li><strong>C</strong>onfusion&nbsp;</li>\n<li>Blood <strong>U</strong>rea Nitrogen (BUN) &gt;7&nbsp;<span class=\"nowrap\">mmol/L</span></li>\n<li><strong>R</strong>espiratory rate &ge;30/min&nbsp;</li>\n<li><strong>B</strong>lood pressure, systolic &le;90 mmHg or diastolic &le;60 mmHg&nbsp;</li>\n<li>Age &ge;<strong>65</strong> years.</li>\n</ul>\n<p>Management:</p>\n<p><span class=\"medCalcFontOneBold\">0 point: Treat as an outpatient</span></p>\n<p><span class=\"medCalcFontOneBold\">1 to 2 points: Admitted to the hospital</span></p>\n<p><span class=\"medCalcFontOneBold\">&ge;3 points: ICU admission</span></p>\n<p><span class=\"medCalcFontOneBold\"><strong>Treatment of Community-Acquired Pneumonia</strong>&nbsp;</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 0: The drug of choice is macrolides. </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Azithromycin 500mg OD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Clarithromycin&nbsp; 500mg BD </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Doxycycline&nbsp; 100mg BD.</span></p>\n<p><span class=\"medCalcFontOneBold\">Score - 1: Treated with azithromycin&nbsp; 500mg OD + ceftriaxone 2gm OD.</span></p>\n<p><span class=\"medCalcFontOneBold\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Respiratory quinolones (Levofloxacin) are not preferred. </span></p>\n<p><span class=\"medCalcFontOneBold\">Score - &gt;2: Azithromycin 500mg OD + Ceftriaxone 2gm IV OD and specific management.<br /></span></p>\n<p>NOTE:- In a<strong> modified </strong>version of the CURB-65, the criteria of blood urea nitrogen has been removed.</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;This elimination removes the need for lab testing.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5307",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a component of Syndrome Z?",
      "choices": [
        {
          "id": 1,
          "text": "Obstructive sleep apnea"
        },
        {
          "id": 2,
          "text": "Blood pressure more than 130/85 mmHg"
        },
        {
          "id": 3,
          "text": "Fasting triglyceride more than150mg/dl"
        },
        {
          "id": 4,
          "text": "LDL more than 100mg/dl"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Syndrome</strong> <strong>Z</strong> is defined as a combination of obstructive sleep apnea syndrome with metabolic&nbsp;syndrome.&nbsp;LDL more than 100 mg/dL&nbsp;is not a criterion for the diagnosis of metabolic&nbsp;syndrome.</p>\n<p><strong>Metabolic syndrome</strong> is diagnosed based on <strong>The NCEP: ATP III Criteria</strong>. <strong>Three or more</strong> of the following must be present :</p>\n<ul>\n<li><strong>Central obesity</strong>: waist circumference &gt;102 cm (M), &gt;88 cm (F)</li>\n<li><strong>Hypertriglyceridemia</strong>: triglyceride level &ge;150 mg/dL or specific medication</li>\n<li><strong>Low HDL</strong> cholesterol: &lt;40 mg/dL and &lt;50 mg/dL for men and women, respectively, or specific medication</li>\n<li><strong>Hypertension</strong>: blood pressure &ge;130 mmHg systolic or &ge;85 mmHg diastolic or specific medication</li>\n<li><strong>Fasting</strong> plasma glucose level <strong>&ge;100 mg/dL</strong> or specific medication or previously diagnosed type 2 diabetes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5298",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a history of a backache for 10 days, has now presented with sudden onset difficulty in micturition and defaecation. There was no history of a cough or fever previously. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Pott’s Spine"
        },
        {
          "id": 2,
          "text": "Guillain Barre Syndrome"
        },
        {
          "id": 3,
          "text": "Cauda Equina Syndrome"
        },
        {
          "id": 4,
          "text": "Multiple Sclerosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This is a case of<strong>&nbsp;cauda equina syndrome (CES).</strong></p>\n<p>CES signifies an injury of multiple lumbosacral nerve roots within the spinal canal distal to the termination of the spinal cord at L1-L2.&nbsp;It is commonly due to a ruptured lumbosacral intervertebral disk, lumbosacral spine fracture, hematoma within the spinal canal, compressive tumor, or other mass lesions.</p>\n<p><strong> Low back pain</strong>, weakness,&nbsp;and areflexia in the legs, saddle anesthesia, or <strong>loss of bladder function</strong> may occur.&nbsp;</p>\n<p>Treatment options include surgical decompression, sometimes urgently in an attempt to restore or preserve motor or sphincter function, or radiotherapy for metastatic tumors.</p><hr><h3>Related Pearl: Conus medullaris syndrome vs Cauda equina syndrome</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Conus medullaris syndrome</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Cauda equina syndrome</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Injury</td>\n<td>\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Vertebral column injuries between T12 and L2</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Vertebral column injuries distal to L2</td>\n</tr>\n<tr>\n<td>Pathophysiology</td>\n<td>\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Upper and lower motor neuron involvement</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Lower motor neuron involvement</td>\n</tr>\n<tr>\n<td>Motor strength&nbsp;</td>\n<td>\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Symmetrical motor impairment&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Asymmetrical motor impairment</td>\n</tr>\n<tr>\n<td>Reflexes</td>\n<td>Knee jerk preserved, ankle jerk affected</td>\n<td>Both knee and ankle jerk affected</td>\n</tr>\n<tr>\n<td>Sphincter dysfunction</td>\n<td>Urinary retention presents early in the disease course</td>\n<td>Urinary retention presents late in the disease course</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Absent bulbocavernosus reflex</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 1126\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Radicular pain and low back pain</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5302",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old male chronic smoker presents to the AIIMS OPD with fever, fatigue, yellow-colored urine, and clay-colored stools. For the past few days, he has developed an aversion to cigarette smoking. On examination icterus was present. What investigations would you advise to rule out acute viral hepatitis? Liver function test results are given below:<div class='question-desc-html'><p>Total Bilirubin – 18.5 <br />Direct Bilirubin – 7.5 <br />SGOT – 723 <br />SGPT – 812</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "HBsAg, IgM antiHBC, AntiHCV, AntiHEV"
        },
        {
          "id": 2,
          "text": "AntiHAV, HBsAg, IgM antiHBc, AntiHCV"
        },
        {
          "id": 3,
          "text": "HBsAg, IgM antiHBc, AntiHDV, AntiHCV, Anti HEV"
        },
        {
          "id": 4,
          "text": "AntiHAV, IgM antiHBc, AntiHCV, AntiHEV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>jaundice</strong>. The<strong> tests</strong> that should be done in this patient to rule out <strong>acute viral hepatitis </strong>include:</p>\n<ul>\n<li>Anti-HAV</li>\n<li>HBsAg</li>\n<li>IgM anti-HBc</li>\n<li>Anti-HCV</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition Suspected</strong></td>\n<td><strong>Targetted Test Performed</strong></td>\n</tr>\n<tr>\n<td>Acute Hepatitis A</td>\n<td>IgM Anti-HAV</td>\n</tr>\n<tr>\n<td>Acute Hepatitis B</td>\n<td>\n<p>HBsAg and</p>\n<p>IgM Anti-HBc</p>\n<p>*1 or both can be positive. A positive IgM AntiHBc with negative HBsAg is seen when HBsAg is below the detection threshold. </p>\n</td>\n</tr>\n<tr>\n<td>Acute Hepatitis C</td>\n<td>Anti HCV</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>We mainly test for hepatitis A, B, and C. Tests for hepatitis D and E are not used routinely.</p>\n<p><strong>Hepatitis D</strong> only occurs concurrently with Hepatitis B, either as a co-infection (when it is clinically indistinguishable from HBV infection) or superimposed on chronic HBV infection. In the latter scenario, it presents as a sudden worsening of the patient’s condition. IgM anti-HDV, IgG anti-HDV, and HDV RNA assays are useful for diagnosis when hepatitis D is suspected.</p>\n<p><strong>Hepatitis E</strong> is <strong>not tested</strong> as the majority of patients who acquire hepatitis E virus (HEV) infection spontaneously clear the virus. Acute hepatic failure is more likely in those who are pregnant and in those who are malnourished or have preexisting liver disease. Chronic HEV has been described almost exclusively in immunocompromised hosts (e.g., organ transplantation). The diagnosis of acute HEV is typically based upon the detection of IgM antibodies to HEV. <strong>B</strong><strong>oth false positives </strong>and <strong>negatives </strong>are<strong> common</strong> with available assays and are thus, not very reliable. Thus, additional serologic testing or HEV RNA testing should be performed to confirm the diagnosis and not be useful as a screening test. [Please note the difference between anti-HBe and anti-HEV]</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5303",
      "difficulty": "hard"
    },
    {
      "text": "A 22-year-old man presented with diarrhea and intolerance to dairy products. On investigation, he was found to have a lactase deficiency. Which of the following agents is least likely to cause symptoms of lactose intolerance?",
      "choices": [
        {
          "id": 1,
          "text": "Condensed Milk"
        },
        {
          "id": 2,
          "text": "Skimmed Milk"
        },
        {
          "id": 3,
          "text": "Yogurt"
        },
        {
          "id": 4,
          "text": "Ice Cream"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Yogurt</strong> is the least likely to cause symptoms of lactose intolerance. It contains<strong> lactobacillus that produces lactase</strong> and is generally well tolerated.</p>\n<p><strong>Lactase </strong>is a brush border enzyme that <strong>hydrolyzes lactose into glucose and galactose</strong>. In lactase deficiency, patients have great variability in clinical symptoms, depending on both the severity of lactase deficiency and the amount of lactose ingested.</p>\n<p>The goal of treatment in patients with isolated lactase deficiency is achieving patient comfort through the elimination of dietary lactose.</p>\n<p>Foods that are <strong>high in lactose</strong> include <strong>milk</strong> (12 g/cup), <strong>ice cream</strong> (9 g/cup), and cottage cheese (8 g/cup). Aged cheese has lower lactose content. Most people can tolerate up to <strong>12g of lactose a day</strong> without significant symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5304",
      "difficulty": "medium"
    },
    {
      "text": "What is the most likely causative organism of ventilator-associated pneumonia among the following?",
      "choices": [
        {
          "id": 1,
          "text": "Clostridium"
        },
        {
          "id": 2,
          "text": "Klebsiella"
        },
        {
          "id": 3,
          "text": "Acinetobacter"
        },
        {
          "id": 4,
          "text": "Hemophilus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options,<strong> Acinetobacter species</strong> is the <strong>most commonly isolated</strong> organism in cases of <strong>ventilator-associated pneumonia (VAP)</strong>.&nbsp;VAP develops in a mechanically ventilated patient <strong>&gt;48 hours </strong>after endotracheal intubation.</p>\n<p>The organisms causing ventilator-associated pneumonia (VAP) significantly vary from one hospital to another. However, the organisms that frequently cause VAP in hospital settings are <strong><em>Staphylococcus aureus</em></strong>, <strong><em>Pseudomonas aeruginosa</em>,&nbsp;</strong><em><strong>Acinetobacter sp.</strong>,&nbsp;Stenotrophomonas maltophilia, </em>and&nbsp;gram-negative rods (Enterobacter species, <em>K. pneumoniae</em>, and <em>Escherichia coli</em>).</p>\n<p>Three factors distinguish nosocomial pneumonia from community-acquired pneumonia:</p>\n<ol>\n<li>Different infectious agent</li>\n<li>Different antibiotic susceptibility patterns, specifically, a higher incidence of drug resistance</li>\n<li>Poorer underlying health status of patients putting them at risk for more severe infections</li>\n</ol>\n<p>Within 48 hours of admission, 75% of seriously ill hospitalized patients have their upper airway colonized with organisms from the hospital environment. Impaired cellular and mechanical defense mechanisms in the lungs of hospitalized patients raise the risk of infection after aspiration has occurred.</p>\n<p>VAP patients may be infected with <em>Acinetobacter</em> species and <em>Stenotrophomonas&nbsp;maltophilia</em>. Anaerobic organisms (<em>Bacteroides</em>, anaerobic streptococci, <em>Fusobacterium</em>) may also cause pneumonia in the hospitalized patient.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5285",
      "difficulty": "medium"
    },
    {
      "text": "The arterial blood gas findings of a patient are pH = 7.12, pCO2 = 50, HCO3 = 28. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Respiratory acidosis with metabolic compensation"
        },
        {
          "id": 2,
          "text": "Metabolic acidosis with respiratory compensation"
        },
        {
          "id": 3,
          "text": "Respiratory alkalosis with metabolic compensation"
        },
        {
          "id": 4,
          "text": "Metabolic alkalosis with respiratory compensation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above findings give the diagnosis of<strong>&nbsp;respiratory acidosis </strong>with<strong> metabolic compensation</strong>.</p>\n<p>Interpretation of the ABG:</p>\n<p>Step 1: pH is reduced (7.12), hence <strong>acidosis</strong>.</p>\n<p>Step 2: Since pCO2 is raised (50 mmHg),&nbsp;it is <strong>respiratory</strong> acidosis.</p>\n<p>Step 3: HCO<sub>3</sub>&nbsp;is raised&nbsp;(28 mEq/L) suggesting there is <strong>metabolic compensation</strong>.</p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Interpretation of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5286",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs is not used in rheumatoid arthritis?",
      "choices": [
        {
          "id": 1,
          "text": "Febuxostat"
        },
        {
          "id": 2,
          "text": "Leflunomide"
        },
        {
          "id": 3,
          "text": "Etanercept"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Febuxostat</strong>&nbsp;is not used in rheumatoid arthritis. It is used in the treatment of <strong>gout</strong>.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5293",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged woman with a history of constipation, dry skin and menorrhagia presents to the ER with altered sensorium, non-pitting edema, hypothermia, bradycardia, and hypotension. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Septic shock"
        },
        {
          "id": 2,
          "text": "Cardiogenic shock"
        },
        {
          "id": 3,
          "text": "Myxedema coma"
        },
        {
          "id": 4,
          "text": "Hypoglycemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical history is typical&nbsp;of a <strong>case of hypothyroidism</strong> and the diagnosis is&nbsp;<strong>myxedema coma</strong>, which is a serious complication of hypothyroidism.</p>\n<p>Myxedema coma is a part of a larger clinical picture of <strong>myxedema crisis.</strong> Myxedema crisis refers to severe, life-threatening manifestations of hypothyroidism. It is often precipitated by the administration of sedatives, antidepressants, hypnotics, anaesthetics, or opioids.</p>\n<p>Clinical features of myxedema crisis :</p>\n<ul>\n<li>Impaired cognition, ranging from confusion to somnolence to coma (<strong>myxedema coma</strong>).</li>\n<li>Convulsions and abnormal CNS signs.</li>\n<li>Profound <strong>hypothermia</strong> (can reach 23&deg;C), hypoventilation,<strong> hyponatremia, hypoglycemia, </strong>hypoxemia<strong>, hypercapnia, </strong>and hypotension.</li>\n<li>Rhabdomyolysis and acute kidney injury</li>\n<li>A high mortality rate&nbsp;</li>\n</ul>\n<p><strong>Other options:&nbsp;</strong></p>\n<p><strong>Option A: </strong>Without a history of or focus of infection, septic shock is unlikely.&nbsp;</p>\n<p><strong>Option B:</strong> Cardiogenic shock would present with symptoms of left heart failure i.e. pitting pedal edema, abdominal distension, prominence of neck veins, and dyspnea.&nbsp;</p>\n<p><strong>Option D:</strong> Hypoglycemia usually presents with sweating, palpitations, and tachycardia&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5291",
      "difficulty": "easy"
    },
    {
      "text": "An elderly diabetic and hypertensive patient was carried to the emergency room in a comatose state. On examination, the blood pressure was 170/100 mmHg and pulse rate was >100/min. Plantar reflex was bilateral extensor. What is the next step to do?",
      "choices": [
        {
          "id": 1,
          "text": "Check blood sugar level"
        },
        {
          "id": 2,
          "text": "Give antihypertensive"
        },
        {
          "id": 3,
          "text": "IV mannitol"
        },
        {
          "id": 4,
          "text": "CT brain"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Ruling out <strong>glycemic</strong> <strong>extremes</strong> is the first step in the evaluation of this patient who is in a <strong>coma</strong> as most of the causes of coma are <strong>metabolic</strong> in origin and with appropriate treatment are completely <strong>reversible</strong>.</p>\n<p>In this elderly patient, with no other relevant history, the most likely cause of coma is <strong>diabetic ketoacidosis, hyperglycemic hyperosmolar state,</strong> or even <strong>hypoglycemia</strong> (which may present with hypertension).</p>\n<p><strong>Other options : </strong></p>\n<p>The patient presents with tachycardia which is not a sign of raised intracranial pressure(bradycardia, altered respiratory pattern, raised systolic blood pressure) and hence starting iv mannitol <strong>(option 3)</strong> to reduce intracranial pressure or doing a CT<strong> (option 4)</strong> to rule out intracranial space-occupying lesion is not required.</p>\n<p>The patient is a known case of hypertension which may cause hypertensive encephalopathy due to cerebral edema and would present with a similar history and signs of raised intracranial pressure giving antihypertensive <strong>(option 2) </strong>&nbsp;medications would treat the condition but it is not the first step as metabolic causes are more common and have to be addressed first.&nbsp;</p>\n<p><strong>Coma</strong> is defined as a deep sleep-like state from which the patient cannot be aroused.Coma could be due to:</p>\n<ul>\n<li aria-level=\"1\"><strong>Metabolic</strong> and toxic encephalopathies, where brain imaging will be normal</li>\n<li aria-level=\"1\">Meningitis syndromes</li>\n<li aria-level=\"1\">Diseases with prominent focal signs like stroke, or hemorrhage</li>\n</ul>\n<p><strong>Urgent intervention </strong>is needed to prevent further brain damage. It is done by providing supplemental <strong>oxygen</strong>, intravenous <strong>thiamine</strong> (at least 100 mg), and intravenous 50% <strong>dextrose</strong> in water (25 g) empirically. It is crucial to measure baseline serum glucose levels before administering glucose.</p>\n<p>The initial examination includes <strong>evaluating</strong> the general appearance,vitals, breath sounds, <strong>response</strong> to stimulation, pupil size and <strong>responsiveness</strong>, and any abnormal posturing or movements. In trauma cases, the neck should be stabilized until ruling out cervical spine fracture. Airway protection and intravenous access is necessary.&nbsp;</p>\n<p><strong>Immediate therapeutic intervention</strong> should be done for hypotension, significant hypertension, bradycardia, arrhythmias affecting blood pressure or marked hyperthermia. Signs of <strong>meningeal irritation</strong> or <strong>fever</strong> indicate the need for urgent <strong>lumbar</strong> <strong>puncture</strong>. <strong>Fundus</strong> examination for papilledema and a CT scan of the brain should be performed prior to lumbar puncture in comatose patients.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5290",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old patient came with a history of hyponatremia. He was treated by a large volume of hypertonic fluids over 24 hours following which the patient developed quadriparesis. What is the most likely cause for this patient’s condition?",
      "choices": [
        {
          "id": 1,
          "text": "Brain infarct"
        },
        {
          "id": 2,
          "text": "Brainstem injury"
        },
        {
          "id": 3,
          "text": "Central pontine myelinolysis"
        },
        {
          "id": 4,
          "text": "Rare cause of hypernatremia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This is a typical history of sudden correction of hyponatremia leading to <strong>central pontine myelinolysis</strong>, a common complication associated with the treatment of hyponatremia.</p>\n<p><strong>Central pontine myelinolysis/ Osmotic demyelination syndrome</strong> is seen due to <strong>rapid correction</strong> of chronic <strong>hyponatremia </strong>(hyponatremia lasting for more than <strong>48 hrs).</strong> It results in the efflux of organic osmolytes from brain cells, which reduces intracellular osmolality and osmotic gradient, and water entry.&nbsp;</p>\n<p>Rapid correction of hyponatremia (&gt;8&ndash;10 mM in 24 h or 18 mM in 48 h) causes <strong>hypertonic</strong> <strong>stress</strong> in astrocytes within the brain causing <strong>demyelination</strong> without inflammation at the base of the pons, with relative <strong>sparing of axons </strong>and<strong> nerve cells.</strong></p>\n<p>Clinically patients present one or more days after overcorrection of hyponatremia with paraparesis or quadriparesis, diplopia, a &ldquo;locked-in syndrome,&rdquo; dysphagia, dysarthria with/without loss of consciousness.&nbsp;</p>\n<p><strong>MRI</strong> is useful in establishing the diagnosis and may also identify partial forms that present as confusion, dysarthria, and/or disturbances of conjugate gaze without paraplegia.</p>\n<p>Prevention can be done by <strong>restoration </strong>of<strong> severe hyponatremia gradually</strong> i.e. by &le;10 mmol/L (10 mEq/L) within 24 h and &le;20 mmol/L (20 mEq/L) within 48 h.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/97db1af1f9ec4e40ad21a8e7dfbbb7e8x477x547.PNG\" alt=\"Explanation Image\"><p>The image shows the MRI finding of central pontine myelinolysis with axial fat saturated T2-Weighted MRI showing hyperintense signal in the central pons.</p>\n<p><strong>Note</strong>: Brain infarct or brain stem injury usually do not result in a quadriparesis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5287",
      "difficulty": "easy"
    },
    {
      "text": "An elderly woman presents with a chronic history of pain in the small joints of hands with stiffness of joints in the early hours of the day. The image of the patient’s hands is given below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Rheumatoid Arthritis"
        },
        {
          "id": 2,
          "text": "Osteoarthritis"
        },
        {
          "id": 3,
          "text": "Complex Regional Pain Syndrome"
        },
        {
          "id": 4,
          "text": "Villonodular synovitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The above image shows <strong>flexion</strong> at the <strong>PIP</strong> joint and <strong>extension</strong> in the <strong>DIP</strong> joints which is known as <strong>boutonniere deformity</strong> which is seen in <strong>rheumatoid arthritis(RA).&nbsp;</strong></p>\n<p>If the patient gives a history of pain/stiffness in the joints in the early hours of the day which usually decreases as the day progresses suggesting <strong>inflammatory arthritis</strong> and if it presents with predominant involvement of <strong>smaller</strong> joints, it is most likely a case of <strong>RA(option A).</strong></p>\n<p>It occurs due to the accumulation of <strong>inflammatory</strong> <strong>mediators</strong> which on increased joint mobility are flushed out due to increased blood supply.&nbsp;</p>\n<p>Pain and stiffness in <strong>osteoarthritis</strong> (Option B) usually <strong>increase</strong> as the day <strong>progresses</strong> due to an increase in the activity of the joint. They typically present with nodules around the distal interphalangeal joint <strong>(Heberden nodes)</strong> and proximal interphalangeal joint <strong>(Bouchard nodes). &nbsp;</strong></p><hr><h3>Related Pearl: Deformities in rheumatoid arthritis</h3><p><strong>Boutonni&egrave;re deformity: </strong>Flexion of the PIP joint with hyperextension of the DIP joint.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0250f1148284de1bd77c8d6e470c56fx720x960.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Swan-neck deformity</strong>: Hyperextension of the PIP joint with flexion of the DIP joint.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/560c6a73ecfc46e7aed6682bc24af2a4x720x1017.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Z line deformity: </strong>Radial deviation of the wrist with ulnar deviation of digits.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c60e1966a5314bbf8fd6c20a5ed7f625x800x600.JPEG\" alt=\"Pearl Image\"><p>Eversion at hindfoot (subtalar joint), hallux valgus (shown below), hammertoe.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/798b7febef7a44699a664b1f1a5363cdx720x919.JPEG\" alt=\"Pearl Image\"><p>Windswept deformities of toes - Valgus deformities of toes in one foot and varus in the other foot.&nbsp;</p>\n<p><strong>Piano-key movement </strong>of the ulnar styloid.&nbsp;</p>\n<p><strong>Trigger finger</strong> due to flexor tendon synovitis.&nbsp;</p><hr><h3>Related Pearl: Classification Criteria for Rheumatoid Arthritis - ACR/EULAR (2010)</h3><table>\n<tbody>\n<tr>\n<td>Criteria</td>\n<td> </td>\n<td>\n<p>Score</p>\n</td>\n</tr>\n<tr>\n<td>Joint involvement</td>\n<td>\n<p> </p>\n<p>1 large joint(shoulder,elbow,hip,knee)</p>\n<p>2-10 large joints</p>\n<p>1-3 small joints(MCP,PIP,IP,MTP,wrist)</p>\n<p>4-10 small joints</p>\n<p>&gt;10 joints(atleast 1 small joint)</p>\n</td>\n<td>\n<p> </p>\n<p> </p>\n<p>0</p>\n<p>1</p>\n<p>2</p>\n<p>3</p>\n<p>5</p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Serology</td>\n<td>\n<p>-ve RF and -ve ACPA</p>\n<p>Low +ve RF or anti-CCP (&lt;3 times ULN)</p>\n<p>High +ve RF or anti-CCP (&gt;3 times ULN)</p>\n</td>\n<td>\n<p>0</p>\n<p>2</p>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td>Acute phase reactants</td>\n<td>\n<p>Normal CRP and ESR</p>\n<p>Abnormal CRP or ESR</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>Duration of symptoms</td>\n<td>\n<p>&lt;6 weeks</p>\n<p>&gt;=6 weeks</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 2898\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Maximum score is 10. A score of ≥6 fulfills requirements for definite RA.</p>\n<p>Abbreviations:</p>\n<ul>\n<li>ACPA, anti-citrullinated peptide antibodies;</li>\n<li>CCP, cyclic citrullinated pep- tides;</li>\n<li>IP, interphalangeal joint;</li>\n<li>MCP, metacarpophalangeal joint;</li>\n<li>MTP, metatarsophalangeal joint;</li>\n<li>PIP, proximal interphalangeal joint;</li>\n<li>RF, rheumatoid factor;</li>\n<li>ULN, upper limit of normal.</li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9ab556c8071442dd931dff04b5748812.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5296",
      "difficulty": "easy"
    },
    {
      "text": "A triad of skin lesions, asymmetric mononeuritis multiplex and eosinophilia is seen in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Cryoglobulinemic vasculitis"
        },
        {
          "id": 2,
          "text": "Polyarteritis nodosa"
        },
        {
          "id": 3,
          "text": "Churg Strauss syndrome"
        },
        {
          "id": 4,
          "text": "Giant cell arteritis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A triad of <strong>skin lesions,</strong> asymmetric<strong> mononeuritis multiplex, </strong>and<strong> eosinophilia</strong> is seen in <strong>Churg&ndash;Strauss syndrome </strong>(eosinophilic&nbsp;granulomatosis with polyangiitis).</p>\n<p>It is a <strong>necrotizing vasculitis</strong> of the small-to-medium-sized vessels and in order to be diagnosed with Churg-Strauss, a patient should have evidence of <strong>asthma</strong>, peripheral blood and tissue <strong>eosinophilia</strong> (&gt;1000 cells/&mu;L), extravascular <strong>granuloma</strong> formation and clinical features consistent with vasculitis.&nbsp;</p>\n<p>Common presenting symptoms of this condition are<strong> lower respiratory tract symptoms </strong>such as severe attacks of asthma, u<strong>pper respiratory tract symptoms</strong> such as allergic rhinitis, sinusitis, and nasal polyps, mono neuritis multiplex (a type of peripheral neuropathy affecting at least two nerves) which presents with a complaint of pain, numbness, or weakness in the affected areas and skin lesions like palpable purpura and subcutaneous nodules.</p>\n<p><strong>Renal involvement</strong> is <strong>less</strong> common and less severe than other small vessel vasculitis.</p>\n<p><strong>P-ANCA</strong> antibodies are present in Churg Strauss syndrome.&nbsp;</p>\n<ul>\n<li>Severe attacks of <strong>asthma</strong></li>\n<li><strong>Mononeuritis multiplex:</strong>&nbsp;a type of peripheral neuropathy affecting at least two nerves. Patients will complain of pain, numbness, or weakness in the affected areas.</li>\n<li><strong>Skin lesions</strong> like palpable purpura and subcutaneous nodules.</li>\n</ul>\n<p><strong>Glucocorticoids</strong> show effective responses in these patients. Other drugs that have been tried are <strong>mepolizumab</strong> and <strong>rituximab</strong>.</p>\n<p>For fulminant multisystem disease, daily <strong>cyclophosphamide</strong> with <strong>prednisolone</strong> followed by <strong>azathioprine</strong> or <strong>methotrexate</strong> is used.</p>\n<p><strong>Option A: Cryoglobulinemic vasculitis</strong> presents with palpable purpura, arthralgia, neuropathy, and glomerulonephritis. &nbsp;It is most commonly associated with <strong>Hepatitis C.</strong></p>\n<p><strong>Option B: Polyarteritis nodosa</strong> can also present with mononeuritis multiplex and skin lesions, but they do <strong>not</strong> have <strong>eosinophilia, </strong>it has predominant<strong> neutrophilia.</strong></p>\n<p><strong>Option D: Giant cell arteritis</strong> manifests with the cardinal symptom of headache localized to the temporal region. Common symptoms include headache, polymyalgia rheumatica , jaw claudication, fever, and decrease in body weight. Laboratory results show increased ESR, CRP levels, normochromic or mildly hypochromic anemia.</p><hr><h3>Related Pearl: Important Vasculitis with Features</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vasculitis</strong></p>\n</td>\n<td>\n<p><strong>Predominant vessel involved</strong></p>\n</td>\n<td>\n<p><strong>Inflammatory cells</strong></p>\n</td>\n<td>\n<p><strong>Other features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Temporal arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>Temporal, vertebral and ophthalmic arteries, aorta</p>\n</td>\n<td>\n<p>Lymphocytes, and macrophages</p>\n</td>\n<td>\n<p>&gt;40 years old, polymyalgia rheumatica, granulomas, giant cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Takayasu Arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>(Medium-sized and large arteries) Aortic arch, great vessels, pulmonary artery, coronary and renal arteries</p>\n</td>\n<td>\n<p>Lymphocytes, macrophages, neutrophils, granulomas, giant cells</p>\n</td>\n<td>\n<p>Pulseless disease</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Polyarteritis Nodosa</strong></p>\n</td>\n<td>\n<p>Small or medium-sized muscular arteries, typically involving renal and visceral vessels</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Spares pulmonary vessels, 30% of patients with&nbsp; chronic hepatitis B</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microscopic polyangiitis</strong></p>\n</td>\n<td>\n<p>Capillaries, small arterioles, venules</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Necrotizing glomerulonephritism (90% of patients) and pulmonary capillaritis leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Churg-Strauss&nbsp;</strong><strong>Syndrome</strong></p>\n</td>\n<td>\n<p>Medium and small arteries</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Eosinophils (required), lymphocytes, macrophages, neutrophils</p>\n</td>\n<td>\n<p>Associated with asthma, allergic rhinitis, lung infiltrates, peripheral hypereosinophilia, and extravascular necrotizing granulomata.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5300",
      "difficulty": "easy"
    },
    {
      "text": "'a' wave in JVP corresponds to?",
      "choices": [
        {
          "id": 1,
          "text": "Right atrial contraction"
        },
        {
          "id": 2,
          "text": "Closure of tricuspid valve"
        },
        {
          "id": 3,
          "text": "Onset of ventricular systole"
        },
        {
          "id": 4,
          "text": "Maximal atrial filling"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The<strong>&nbsp;\"a\" wave</strong> in jugular venous pressure (JVP) is a positive wave, which corresponds to<strong>&nbsp;right atrial contraction.</strong></p>\n<p>The waveforms seen in a normal JVP are:</p>\n<ul>\n<li>a wave corresponds to atrial contraction and occurs just after the P wave (on ECG) and just before the first heart sound.</li>\n<li>c wave represents the bulging of the tricuspid valve into the right atrium during ventricular systole.</li>\n<li>x descent corresponds to the atrial relaxation during atrial diastole.</li>\n<li>v wave represents atrial filling during ventricular systole and peaks at the second heart sound.</li>\n<li>y descent represents passive emptying of the right atrium into the right ventricle after tricuspid valve opening.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/29c964e05da6489d9d243a1f25e8a032x1280x1005.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: JVP waveform and the abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\" alt=\"Pearl Image\"><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5305",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following is wrong about DIC?",
      "choices": [
        {
          "id": 1,
          "text": "Increased schistocytes"
        },
        {
          "id": 2,
          "text": "Increased PT"
        },
        {
          "id": 3,
          "text": "Increased fibrinogen"
        },
        {
          "id": 4,
          "text": "Increased FDPs"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In disseminated intravascular coagulopathy (DIC), <strong>fibrinogen levels</strong> are<strong> decreased</strong>&nbsp;due to increased bleeding.&nbsp;</p>\n<p>Disseminated intravascular coagulation (DIC) is an <strong>acquired</strong> syndrome characterized by the <strong>widespread activation</strong> of blood clotting factors within blood vessels, resulting in a loss of clotting control. The primary mechanism of DIC involves the uncontrolled generation of <strong>thrombin</strong> through multiple pathways which leads to sustained <strong>coagulation activation</strong>, the formation of <strong>fibrin</strong>, and the consumption of clotting factors and platelets.</p>\n<p><strong>Infections</strong> are the most frequent cause of DIC.</p>\n<p><strong>Laboratory investigations in DIC:</strong></p>\n<ul>\n<li>Decreased platelet count&nbsp;</li>\n<li>Prolonged PT/TT</li>\n<li>Prolonged activated partial thromboplastin time (aPTT)</li>\n<li>Decreased fibrinogen</li>\n<li>Elevated fibrin degradation products (D-dimers)</li>\n<li>Peripheral smear: microangiopathic hemolytic anemia in DIC with schistocytes (fragmented red blood cells)&nbsp;</li>\n</ul>\n<p>The treatment involves <strong>platelet</strong> <strong>transfusion</strong> when platelet counts are <strong>below 10,000-20,000/</strong>&mu;L. Replacement of fibrinogen and coagulation factors is with<strong> fresh frozen plasma (FFP) </strong>along with <strong>cryoprecipitate</strong> or <strong>fibrinogen</strong> <strong>concentrate</strong>.</p>\n<p>In cases of low-grade DIC associated with solid tumors or acute promyelocytic leukemia <strong>low</strong> doses of <strong>continuous-infusion heparin</strong> has been effective.</p><hr><h3>Related Pearl: Parameters of the coagulation pathway and its uses</h3><p><strong> Parameters of the coagulation pathway and its uses</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter </strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>Prothrombin Time (PT)</td>\n<td>It is used to monitor the functioning of the extrinsic and the common coagulation pathways. Normal PT is 11–13 seconds.</td>\n</tr>\n<tr>\n<td>Activated partial thromboplastin time (aPTT)</td>\n<td>It is used to monitor the functioning of the intrinsic and the common coagulation pathways. Normal aPTT is 25–35 seconds. A relatively rare cause of prolonged aPTT is the presence of antibodies against coagulation plasma proteins called inhibitors. It can be seen due to the following reasons: Hemophilia A and B patients receiving clotting factors to control their bleeding episodes, Pregnancy, Autoimmune diseases, Malignancies (lymphoma, prostate cancer), and Dermatologic conditions.</td>\n</tr>\n<tr>\n<td>Thrombin time (TT)</td>\n<td>It is used for testing the conversion of fibrinogen into fibrin and depends on adequate fibrinogen levels. </td>\n</tr>\n<tr>\n<td>Bleeding time (BT)</td>\n<td>It is the time taken for a standardized skin puncture to stop bleeding. It tests the ability of blood vessels to constrict and platelets to form a hemostatic plug. </td>\n</tr>\n<tr>\n<td>Fibrin degradation products (FDPs)</td>\n<td>They are used to assess the fibrinolytic activity, and they are increased in disseminated intravascular coagulation (DIC). </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Summary of Laboratory findings in Hemostatic Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard&ndash; Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5306",
      "difficulty": "medium"
    },
    {
      "text": "A 16-year-old girl, who is taking antiepileptics, has had a seizure-free period of 6 months. She has no family history of epilepsy. Her EEG is now normal and she has a normal neurological exam and intelligence. What would your advice be?",
      "choices": [
        {
          "id": 1,
          "text": "Stop the treatment and follow up"
        },
        {
          "id": 2,
          "text": "Gradually taper the drug and stop treatment"
        },
        {
          "id": 3,
          "text": "Continue treatment for another 18 months"
        },
        {
          "id": 4,
          "text": "Continue lifelong treatment with antiepileptics"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario of a girl on <strong>antiepileptics</strong> for<strong> 6 months</strong> with <strong>no further seizures,</strong> no family history, normal EEG, neurological examination, and intelligence, antiepileptics should be continued for another <strong>18 months</strong> since she&rsquo;s already taken fo<strong>r 6 months (minimum 2 years) </strong>to prevent seizure <strong>recurrence</strong>.</p>\n<p>Anti-epileptic drugs <strong>withdrawal</strong> is considered only when an adult patient has been <strong>seizure-free for &ge;2 years </strong>along with the following <strong>criteria</strong>:</p>\n<ul>\n<li>Normal CNS examination including intelligence</li>\n<li>Normal EEG and normal MRI</li>\n<li>Single seizure type</li>\n<li>No family history of epilepsy.</li>\n</ul>\n<p>It is preferable to reduce the dose of the drug <strong>gradually</strong> over <strong>2&ndash;3 months.</strong></p><p>Other options:</p>\n<p>Option A: <strong>Sudden cessation</strong> of drug therapy may cause <strong>recurrence</strong> of seizure hence not advised.</p>\n<p>Option B: The patient has a seizure-free interval of only 6 months and therefore, is not yet eligible for considering medication withdrawal.</p>\n<p>Option D: Life-long treatment is not necessary in this case as the patient meets all the above-mentioned criteria for drug withdrawal after 2 years.</p>\n<p>Note: <strong>Juvenile myoclonic epilepsy</strong> (JME), the most common idiopathic generalized epilepsy syndrome is known to have a high risk of seizure recurrence, and hence <strong>antiepileptics</strong> are continued <strong>lifelong</strong> in a majority of patients.</p><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7033",
      "difficulty": "medium"
    },
    {
      "text": "AKIN  and RIFLE criteria are used to classify",
      "choices": [
        {
          "id": 1,
          "text": "Acute kidney injury"
        },
        {
          "id": 2,
          "text": "Chronic renal failure"
        },
        {
          "id": 3,
          "text": "Acute glomerulonephritis"
        },
        {
          "id": 4,
          "text": "Nephrotic syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>AKIN</strong> and <strong>RIFLE criteria</strong> are used to <strong>classify acute kidney injury</strong> (AKI).</p>\n<p>The various classifications used in AKI are:</p>\n<ul>\n<li>RIFLE criteria (Risk, Injury, Failure, Loss, End-stage)</li>\n<li>AKIN (AKI Network) Classification</li>\n<li>KDIGO (Kidney Disease Improving Global Outcomes) Classification</li>\n</ul>\n<p><strong>RIFLE, AKIN, KDIGO definitions</strong> of AKI:</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>RIFLE</td>\n<td>AKIN</td>\n<td>KDIGO</td>\n</tr>\n<tr>\n<td>S. creatinine</td>\n<td>&gt;50% increase that develops in &lt;7 days </td>\n<td>&gt;0.3 mg/dl increase or &gt;50% increase that develops in &lt;48hr</td>\n<td>&gt;0.3 mg/dl increase or &gt;50% increase that develops in &lt;7 days</td>\n</tr>\n<tr>\n<td>Urine output</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n<td>&lt;0.5ml/kg/hr for &gt;6 hr</td>\n</tr>\n<tr>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><strong>RIFLE, AKIN, KDIGO staging </strong>of AKI:</p>\n<table>\n<tbody>\n<tr>\n<td>RIFLE</td>\n<td>Increase in S.creatinine </td>\n<td>AKIN</td>\n<td>Increase in S.creatinine</td>\n<td>KDIGO</td>\n<td>Increase in S.creatinine</td>\n<td>Urine output</td>\n</tr>\n<tr>\n<td><strong>R</strong>isk </td>\n<td>≥50%</td>\n<td>Stage 1</td>\n<td>≥0.3mg/dl or ≥50%</td>\n<td>Stage 1</td>\n<td>≥0.3mg/dl or ≥50%</td>\n<td>&lt;0.5mL/kg/hr for &gt;6h</td>\n</tr>\n<tr>\n<td><strong>I</strong>njury</td>\n<td>≥100%</td>\n<td>Stage 2</td>\n<td>≥100%</td>\n<td>Stage 2</td>\n<td>≥100%</td>\n<td>&lt;0.5mL/kg/hr for &gt;12 hr</td>\n</tr>\n<tr>\n<td><strong>F</strong>ailure</td>\n<td>≥200%</td>\n<td>Stage 3</td>\n<td>≥200%</td>\n<td>Stage 3</td>\n<td>≥200%</td>\n<td>&lt;0.3mL/kg/hr for &gt;24hr or anuria &gt;12hr</td>\n</tr>\n<tr>\n<td><strong>L</strong>oss</td>\n<td>Need for renal replacement therapy (RRT)&gt;4 weeks</td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td><strong>E</strong>nd-stage</td>\n<td>Need RRT for &gt;3 months</td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1403",
      "difficulty": "easy"
    },
    {
      "text": "The most common bleeding manifestation seen in severe hemophilia is:",
      "choices": [
        {
          "id": 1,
          "text": "Recurrent hematomas"
        },
        {
          "id": 2,
          "text": "Recurrent hemarthrosis"
        },
        {
          "id": 3,
          "text": "Hematuria"
        },
        {
          "id": 4,
          "text": "Intracranial hemorrhage"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Recurrent hemarthrosis</strong> is the <strong>most common</strong> bleeding manifestation of <strong>severe</strong> hemophilia.&nbsp;Hemophilia is said to be severe when the residual activity of factor VIII is <strong>&lt;1%</strong>.</p>\n<p>Hemophilia is an <strong>X-linked recessive </strong>hemorrhagic disorder and is caused by mutations in either the <strong>F8 gene (hemophilia A</strong> or classic hemophilia) or the<strong> F9 gene (hemophilia B).</strong> Clinically, it is impossible to distinguish between hemophilia A and hemophilia B as they present with <strong>similar symptoms. </strong>It can be classified based on residual activity of <strong>FVIII </strong>or<strong>&nbsp;FIX</strong> as severe (&lt;1%), moderate (1&ndash;5%), or mild (6&ndash;30% )&nbsp;</p>\n<p>Hemophilia presents early in life- <strong>bleeding after circumcision</strong> or when beginning to walk or crawl.</p>\n<p>Clinical features:</p>\n<ul>\n<li>Acute hemarthrosis:\n<ul>\n<li>Local pain, swelling</li>\n<li>Erythema</li>\n<li>Muscle contractures due to fixed positioning.</li>\n</ul>\n</li>\n<li>Chronic hemarthrosis:\n<ul>\n<li>Synovial thickening</li>\n<li>Synovitis (due to intraarticular blood)</li>\n</ul>\n</li>\n</ul>\n<p>The most common joint affected is the<strong> knee</strong>. One joint is affected more than the other. This is called the <strong>target joint</strong>. Muscle hematomas can lead to compartment syndromes.</p>\n<p>Hematuria is common but self-limited. Life-threatening bleeds such as bleeding into oropharyngeal spaces, CNS, and retroperitoneum can occur.</p>\n<p><strong>Treatment:</strong> Without treatment, severe hemophilia may limit life expectancy. <strong>Factor replacement</strong> for hemophilia has been the mainstay of therapy.</p>\n<ul>\n<li><strong>FVIII dose (IU)</strong> = Target FVIII levels &ndash; FVIII baseline levels &times; body weight (kg) &times; 0.5 unit/kg&nbsp; .</li>\n<li><strong>FIX dose (IU)</strong> = Target FIX levels &ndash; FIX baseline levels &times; body weight (kg) &times; 1 unit/kg&nbsp;</li>\n</ul>\n<p>The FVIII half-life of 8&ndash;12 h requires injections twice a day to maintain therapeutic levels, whereas the FIX half-life is longer, ~24 h so that once-a-day injection is sufficient.&nbsp;</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Differences between Bleeding Disorders and Coagulation disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Finding</strong></td>\n<td><strong>Bleeding disorders</strong></td>\n<td><strong>Coagulation disorders</strong></td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>\n<p>Quantitative/ Qualitative platelet abnormality</p>\n</td>\n<td>Deficiency of clotting factors</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>More common in females (commonly autoimmune)</td>\n<td>More common in males (commonly X-linked)</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Rare (except in VWD)</td>\n<td>Common</td>\n</tr>\n<tr>\n<td>Petechiae</td>\n<td>Characteristic</td>\n<td>&nbsp;Rare</td>\n</tr>\n<tr>\n<td>Superficial ecchymosis</td>\n<td>Small and Multiple</td>\n<td>Large and Solitary</td>\n</tr>\n<tr>\n<td>Bleeding from superficial cuts&nbsp;</td>\n<td>Profuse</td>\n<td>Minimal persistent</td>\n</tr>\n<tr>\n<td>Hemarthrosis</td>\n<td>Rare</td>\n<td>Characteristic (most common-knee)</td>\n</tr>\n<tr>\n<td>Deep dissecting hematomas</td>\n<td>Rare</td>\n<td>Characteristic (most common-iliopsoas)</td>\n</tr>\n<tr>\n<td>Laboratory tests</td>\n<td>Bleeding time is prolonged</td>\n<td>PT and/or PTT are prolonged</td>\n</tr>\n<tr>\n<td>Most common</td>\n<td>Inherited: VWD</td>\n<td>\n<p>Inherited: Hemophilia A</p>\n<p>Acquired: Hemorrhagic diathesis of liver disease</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>VWD:&nbsp;von Willebrand disease</p>\n<p>PT: Prothrombin time</p>\n<p>PTT: Partial thromboplastin time</p><hr><h3>Related Pearl: Summary of Laboratory findings in Hemostatic Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard&ndash; Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>&uarr; (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1975",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with left-sided facial paralysis and left-sided limb weakness for the past 1 hour. Her blood pressure is 160/100 mm Hg and her CT appears normal. What would be the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "Nothing, since CT was normal"
        },
        {
          "id": 2,
          "text": "Start on aspirin + clopidogrel"
        },
        {
          "id": 3,
          "text": "Intravenous thrombolysis"
        },
        {
          "id": 4,
          "text": "Advice BP control"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Sudden onset hemiparesis</strong> with apparently normal CT indicates<strong> ischemic stroke</strong> in this patient.<strong> Intravenous thrombolysis</strong>(alteplase 0.9 mg/kg ) should be immediately administered to patients with ischemic stroke who arrive in the window period i.e., within 3-4.5 hours of symptom onset.</p>\n<p><strong>Aspirin + clopidogrel</strong>(Option B) is used in secondary prevention of stroke and also to prevent stroke following TIA.</p>\n<p><strong> Transient ischemic attacks</strong> (TIAs) refer to episodes of stroke symptoms that have a brief duration, the standard definition of duration is &lt;24 h, but most TIAs <strong>last &lt;1 hr</strong>. TIAs may arise from <strong>emboli</strong> to the brain or from in situ <strong>thrombosis</strong> of an intracranial vessel. With a TIA, the occluded blood vessel reopens and neurologic function is restored. If a relevant brain infarction is identified on brain imaging, the clinical entity is now classified as <strong>stroke</strong> regardless of the duration of symptoms.</p>\n<p>The risk of stroke following a transient ischemic attack (TIA) is approximately 10-15% in the first three months, majorly in the first two days. A reliable estimation of this risk can be obtained using the <strong>ABCD2 score</strong>.&nbsp;<br /><br />Other options:&nbsp;</p>\n<p>Option A: If CT is normal it only rules out <strong>hemorrhagic stroke</strong> and changes of ischemic stroke usually take time to appear on NCCT.</p>\n<p>Option D: BP control is done when <strong>BP exceeds 220/120 mmHg</strong>, if there is malignant hypertension or concomitant myocardial ischemia, or if blood pressure is &gt;185/110 mmHg and thrombolytic therapy is anticipated.&nbsp;</p><hr><h3>Related Pearl: Indications and Contraindications of thrombolysis in Ischemic Stroke</h3><p><strong>Indications for thrombolysis in stroke</strong>&nbsp;</p>\n<ul>\n<li>Clinical diagnosis of stroke</li>\n<li>Onset of symptoms to time of drug administration &lt;3 hours/<strong>4.5</strong> hours</li>\n<li>Age &ge; 18 years</li>\n<li>CT scan showing no haemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory&nbsp;</li>\n</ul>\n<p><strong>Contraindications of thrombolysis in stroke&nbsp;</strong></p>\n<ul>\n<li>Sustained BP &gt;185/110 mmHg despite treatment</li>\n<li>Bleeding diathesis</li>\n<li>Recent head injury or Intracerebral hemorrhage</li>\n<li>Major surgery in preceding 14 days</li>\n<li>Minor stroke symptoms</li>\n<li>Gastrointestinal bleeding in preceding 21 days</li>\n<li>Recent myocardial infarction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7074",
      "difficulty": "medium"
    },
    {
      "text": "Relative bradycardia occurs in:",
      "choices": [
        {
          "id": 1,
          "text": "Typhoid fever"
        },
        {
          "id": 2,
          "text": "Q fever"
        },
        {
          "id": 3,
          "text": "Leptospirosis"
        },
        {
          "id": 4,
          "text": "All of the above"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given options <strong>typhoid, Q fever, and leptospirosis </strong>are infectious causes of relative bradycardia.</p>\n<p><strong>Relative bradycardia,</strong> also known as <strong>Faget's sign</strong>, is observed when patients exhibit a lower heart rate than anticipated in relation to an increase in body temperature. Body temperature is commonly regarded as a factor that independently influences heart rate. It is estimated that for each 1&deg;C (1.8&deg;F) rise in temperature, the heart rate typically increases by approximately 15-20 beats per minute.</p>\n<p>While this pulse-temperature dissociation is not highly sensitive or specific for establishing a diagnosis, it can still prove beneficial in resource-limited settings due to its easy accessibility and simplicity.</p>\n<p><span>Infectious causes of relative bradycardia include:&nbsp;</span></p>\n<ul>\n<li><em>Salmonella typhi</em></li>\n<li><em>Francisella tularensis</em></li>\n<li><em>Coxiella burnetii</em> (Q fever)</li>\n<li><em>Leptospira interrogans</em></li>\n<li><em>Legionella pneumophila</em></li>\n<li><em>Rickettsia</em> spp.</li>\n<li><em>Orientia tsutsugamushi</em> (scrub typhus)</li>\n<li><em>Corynebacterium diphtheriae</em></li>\n<li><em>Plasmodium</em> spp. (malaria)</li>\n</ul>\n<p>Noninfectious causes include:</p>\n<ul>\n<li>Drug fever</li>\n<li>Beta-blocker use</li>\n<li>Central nervous system lesions</li>\n<li>Malignant lymphoma</li>\n<li>Factitious fever</li>\n</ul><p>It was found that relative bradycardia as a feature of specific disease only occurs in diseases caused by organisms that are both gram-negative and intracellular.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6644",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most specific marker for alcoholism?",
      "choices": [
        {
          "id": 1,
          "text": "ALT"
        },
        {
          "id": 2,
          "text": "GGT"
        },
        {
          "id": 3,
          "text": "ALP"
        },
        {
          "id": 4,
          "text": "LDH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>GGT</strong> (Gamma Glutamyl Transferase) is the most<strong> specific</strong> marker of <strong>alcoholism</strong> among the given options.</p>\n<p>The markers with <strong>&gt;60% sensitivity</strong> and <strong>specificity</strong> for heavy alcohol use are <strong>gamma-glutamyl transferase</strong> (&gt;35 u) and <strong>carbohydrate-deficient transferrin</strong> (CDT), the combination of the two is likely to be more accurate than one. An isolated elevation in serum GGT or GGT elevation out of proportion to that of other enzymes (such as the ALT and ALP) may be an indicator of alcohol abuse or alcoholic liver disease.&nbsp;</p>\n<p><strong>ALT (option A)</strong> is usually elevated in acute hepatocellular conditions such as hepatitis. Alanine aminotransferase is predominantly found in the liver, hence a more specific marker of liver injury. A ratio of AST/ALT &gt; 2:1 indicates the possibility of alcoholic liver disease and &gt; 3:1 ratio is highly indicative of this condition. In alcoholic liver disease, ALT levels are often normal.</p>\n<p><strong>ALP (option C)</strong> is elevated in <strong>cholestasis</strong>, ​​is also elevated when there is rapid bone growth like in children and adolescents because of bone alkaline phosphatase and in normal pregnancies due to placental alkaline phosphatase.</p>\n<p><strong>LDH (option D)</strong> elevation is nonspecific.&nbsp;</p><hr><h3>Related Pearl: Laboratory Evaluation of Liver Disease</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test Category</strong></p>\n</td>\n<td>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte integrity</p>\n</td>\n<td>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biliary excretory function</p>\n</td>\n<td>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum &gamma;-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7089",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a differentiating feature between cardiac tamponade and tension pneumothorax?",
      "choices": [
        {
          "id": 1,
          "text": "Breath sounds"
        },
        {
          "id": 2,
          "text": "Muffled heart sounds"
        },
        {
          "id": 3,
          "text": "Increased heart rate"
        },
        {
          "id": 4,
          "text": "Raised JVP"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The differentiating feature between cardiac tamponade and tension pneumothorax is breath sounds.&nbsp;The <strong>breath sounds</strong> are <strong>absent</strong> in <strong>tension pneumothorax</strong> while they are <strong>present in cardiac tamponade.</strong></p>\n<p>The presence of <strong>hypotension</strong>, d<strong>istended jugular veins, </strong>and <strong>muffled heart sounds (Beck's triad)</strong> suggest a <strong>cardiac tamponade.</strong> These features can also be seen in <strong>tension pneumothorax. </strong>Other clinical features pointing towards tension pneumothorax are <strong>absent breath sounds, hyper resonance to percussion, </strong>and <strong>shift</strong> of the <strong>mediastinum</strong> to the contralateral side.&nbsp;</p>\n<p>Heart sounds can be muffled by structures between the stethoscope and the heart, eg, adipose tissue deposition (obesity), fluid accumulation (pericardial effusion, pleural effusion), gas accumulation (pneumothorax, subcutaneous emphysema), soft tissue masses can lead to attenuation of heart sounds.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7092",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with chronic diarrhea and steatorrhea. D-xylose test was normal and the Schilling test was abnormal. A duodenal biopsy was normal. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Celiac disease"
        },
        {
          "id": 2,
          "text": "Ulcerative colitis"
        },
        {
          "id": 3,
          "text": "Intestinal lymphangiectasia"
        },
        {
          "id": 4,
          "text": "Pancreatic insufficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario describes a case of <strong>malabsorption syndrome </strong>(chronic diarrhea and steatorrhea), a <strong>normal xylose</strong> test and <strong>normal duodenal</strong> biopsy with <strong>abnormal</strong> <strong>schilling</strong> test points towards pancreatic insufficiency.</p>\n<p>A normal xylose test and normal duodenal biopsy rules out small intestinal pathologies like <strong>celiac disease </strong>(option A) and <strong>intestinal lymphangiectasia </strong>(option C), presence of steatorrhea rules out <strong>ulcerative colitis </strong>(option B) as it affects the large bowel which is not the main site of absorption of fat.&nbsp;&nbsp;</p>\n<p><strong>Ileal disease</strong> is also characterized by normal xylose test, normal duodenal biopsy and steatorrhea and abnormal schilling test but among the given options the most appropriate answer would be pancreatic insufficiency due to chronic pancreatitis.</p>\n<p><strong>Pancreatic insufficiency</strong> is characterised by the deficiency of exocrine pancreatic enzymes that result in maldigestion and malabsorption.</p>\n<p>The features in favor of the diagnosis:</p>\n<ul>\n<li><strong>Steatorrhea</strong> - a deficiency of pancreatic lipases can lead to <strong>undigested fat</strong> in stools.</li>\n<li><strong>D-xylose test</strong> - d-xylose is a monosaccharide that is directly absorbed by the intestinal mucosa without undergoing any enzymatic action. <strong>Normal</strong> d-xylose test denotes <strong>intact mucosa.</strong></li>\n<li><strong>Schilling test</strong> - it is abnormal as pancreatic enzymes are required for the absorption of vitamin B12.</li>\n</ul>\n<p><br />Diagnosis of various malabsorption syndromes:<br /><br /></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Pathologies</strong></td>\n<td><strong>D xylose test</strong></td>\n<td><strong>Duodenal mucosal biopsy</strong></td>\n<td><strong>Schilling test</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>Decreased&nbsp;</td>\n<td>Abnormal; Short or absent villi; epithelial cell damage; crypts hypertrophy</td>\n<td>Normal&nbsp;</td>\n</tr>\n<tr>\n<td>Ileal disease</td>\n<td>Normal&nbsp;</td>\n<td>Normal&nbsp;</td>\n<td>Abnormal</td>\n</tr>\n<tr>\n<td>Chronic pancreatitis</td>\n<td>Normal&nbsp;</td>\n<td>Normal&nbsp;</td>\n<td>Abnormal; normal after pancreatic enzymes substitution</td>\n</tr>\n<tr>\n<td>Intestinal lymphangiectasia</td>\n<td>Normal&nbsp;</td>\n<td>Abnormal; dilated lymphatics, clubbed villi</td>\n<td>Normal&nbsp;</td>\n</tr>\n<tr>\n<td>Bacterial overgrowth syndrome</td>\n<td>Normal or may be abnormal&nbsp;</td>\n<td>Usually normal or can have diffuse non specific damage to villi</td>\n<td>Usually abnormal; normal after antibiotics administration</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Schilling Test</h3><p>The Schilling test is done to determine the <strong>cause</strong> of <strong>vitamin B12 deficiency.</strong> It involves the administration of radiolabeled vitamin B12&nbsp;followed by the 24-hour&nbsp;collection of urine. The test is then repeated with an&nbsp;additional component&nbsp;that can promote vitamin B12 absorption.&nbsp;If the additional component is able to correct the defect and radiolabeled vitamin B12 is absorbed, it will be detected in the urine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5d3f9735577a4affb67cd119f1540ba0x1280x2246.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7093",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following leads would show maximum R wave with the cardiac axis as +90 degrees?",
      "choices": [
        {
          "id": 1,
          "text": "Lead aVF"
        },
        {
          "id": 2,
          "text": "Lead aVL"
        },
        {
          "id": 3,
          "text": "Lead I"
        },
        {
          "id": 4,
          "text": "Lead II"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>With the cardiac axis at&nbsp;<strong>+90 degrees,</strong>&nbsp;lead <strong>aVF</strong> would show the <strong>maximum R </strong>wave.&nbsp;</p>\n<p>The <strong>cardiac axis</strong> represents the <strong>mean QRS axis&nbsp;</strong>(direction of mean depolarization vector).</p>\n<p>The normal adult QRS axis is directed downward and to the left, which&nbsp;is between <strong>-30&nbsp;degrees&nbsp;</strong>and<strong> +100&nbsp;degrees.</strong></p>\n<p>The position of lead aVF is at +90 degrees. If the cardiac axis is also at +90 degrees, it would be in the same direction as lead aVF and hence aVF would show maximum R wave amplitude.</p>\n<p class=\"p1\">If the mean axis is:</p>\n<ul>\n<li class=\"p1\">More negative than <strong>&ndash;30 degrees:</strong>&nbsp;left axis deviation</li>\n<li class=\"p1\">More positive than <strong>+90 to +100 degrees:</strong>&nbsp;right axis deviation</li>\n<li class=\"p1\">Lies between <strong>-90 to +180 degrees:</strong> extreme axis deviation</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/13d3e5eab7d04922bed9fc140221676ax1280x1625.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: ECG Leads</h3><p>LA &ndash; Left arm: RA &ndash; Right arm: LL &ndash; Left leg: LF &ndash; Left foot</p>\n<ul>\n<li><strong>Limb leads measure the electrical activity in the frontal plane</strong></li>\n<li><strong>Chest leads measure the electrical activity in the horizontal plane<br /><br /><br /></strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td rowspan=\"2\">Limb Lead</td>\n<td colspan=\"2\">Location</td>\n<td rowspan=\"2\">Augmented limb leads</td>\n<td rowspan=\"2\">Location</td>\n<td rowspan=\"2\">Chest leads</td>\n<td rowspan=\"2\">Location</td>\n</tr>\n<tr>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>I</td>\n<td>LA<br /><br /></td>\n<td>&nbsp;RA</td>\n<td>aVF</td>\n<td>LF +ve</td>\n<td>V1</td>\n<td>4th intercostal space. just to the right of the sternum</td>\n</tr>\n<tr>\n<td>II</td>\n<td>LL<br /><br /></td>\n<td>&nbsp;RA</td>\n<td>aVL</td>\n<td>LA +ve</td>\n<td>V2</td>\n<td>4th intercostal space. just to the left of the sternum</td>\n</tr>\n<tr>\n<td>III</td>\n<td>LL<br /><br /></td>\n<td>LA&nbsp;</td>\n<td>aVR</td>\n<td>RA +ve</td>\n<td>V3</td>\n<td>midway between V2 and V4</td>\n</tr>\n<tr>\n<td colspan=\"5\" rowspan=\"3\">&nbsp;</td>\n<td>V4</td>\n<td>Midclavicular line. fifth intercostal</td>\n</tr>\n<tr>\n<td>V5</td>\n<td>Anterior axillary line, same level as V4</td>\n</tr>\n<tr>\n<td>V6</td>\n<td>Midaxillary line, the same level as V4 and V5</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7075",
      "difficulty": "medium"
    },
    {
      "text": "A patient walks with a stomping gait. When asked to close his eyes and walk, he is unable to do so. Which of the following tracts is probably affected?",
      "choices": [
        {
          "id": 1,
          "text": "Spinocerebellar tract"
        },
        {
          "id": 2,
          "text": "Posterior column tract"
        },
        {
          "id": 3,
          "text": "Vestibulospinal tract"
        },
        {
          "id": 4,
          "text": "Rubrospinal tract"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of the involvement of the<strong> posterior column. </strong></p>\n<p>Posterior column carries<strong> proprioception</strong>&nbsp;which is essential for coordination of motor movements. Loss of this leads to the development of a <strong>stomping gait. </strong>This is seen in cases of<strong> vitamin B12 deficiency </strong>leading to subacute combined degeneration, tabes dorsalis&nbsp;or diabetic neuropathy.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7044",
      "difficulty": "medium"
    },
    {
      "text": "A patient with thalassemia has a history of multiple blood transfusions, iron overload, and cardiac arrhythmia. She has now come for blood transfusion and during the process, complains of backache and looks very anxious. What would you do next?",
      "choices": [
        {
          "id": 1,
          "text": "Stop the blood transfusion"
        },
        {
          "id": 2,
          "text": "Continue the transfusion but do an ECG"
        },
        {
          "id": 3,
          "text": "Stop the transfusion. Wait for patient to become normal and then start it again"
        },
        {
          "id": 4,
          "text": "Do clerical check and get ECG"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The patient&nbsp;is being<strong> transfused blood</strong> and has complaints of backache<strong>, </strong>this is suggestive of an <strong>acute hemolytic transfusion reaction. </strong></p>\n<p>The first step is to stop transfusion immediately and then collect<strong> blood samples</strong> for testing.</p>\n<p>Acute hemolytic transfusion reactions typically occur within the <strong>first 24 hours </strong>following a blood transfusion, primarily due to <strong>ABO incompatibility</strong>.</p>\n<p>It presents with symptoms such as hypotension, tachypnea, tachycardia, fever (1-2&deg;C increase in temperature), chills, chest and back pain, hemoglobinuria, and hemoglobinemia. In severe cases, disseminated intravascular coagulation (DIC), acute renal failure, shock, and death can occur.</p>\n<p>Management of immune-mediated acute hemolytic transfusion reactions is to provide supportive care, administer vigorous hydration with isotonic saline and use diuretics to maintain urine output.</p><hr><h3>Related Pearl: Blood Transfusion Reactions</h3><table>\n<tbody>\n<tr>\n<td colspan=\"4\"><span><strong>Immunological Transfusion Reactions</strong>&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Reaction<br /></strong></span><span><strong>(Onset)</strong></span></p>\n</td>\n<td><span><strong>Mechanism</strong></span></td>\n<td><span><strong>Presentation</strong></span></td>\n<td><span><strong>Management</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Anaphylactic transfusion reaction</strong></span></p>\n<p><span>(Seconds-minutes)</span></p>\n</td>\n<td>\n<p><span>Common in<strong> IgA</strong> deficient recipients&nbsp;</span></p>\n</td>\n<td>\n<p><span>Shock, respiratory distress, angioedema</span></p>\n</td>\n<td>\n<p>Stop transfusion immediately, give epinephrine</p>\n<p><span>Prevention &ndash; using IgA deficient plasma and washed cellular blood components</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Allergic/ Urticarial transfusion reaction</strong></span></p>\n<p><span>(Within 2-3 hours)</span></p>\n</td>\n<td>\n<p><span>Recipient <strong>IgE</strong> against donor components causing mast cell activation</span></p>\n</td>\n<td>\n<p><span>Urticaria, flushing, pruritus</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Febrile non-hemolytic transfusion reaction</strong></span></p>\n<p><span>(within&nbsp;</span><span>6h)</span></p>\n<p>&nbsp;</p>\n<p><span><span>(Most common complication of blood transfusion)</span></span></p>\n</td>\n<td>\n<p><span>Antibodies against donor WBC and <strong>HLA</strong> antigens (sensitization)</span></p>\n<p><span>Cytokine accumulation during blood storage</span></p>\n<p><span>More common in multipally transfused patients and multiparous women</span></p>\n</td>\n<td>\n<p><span>Fever and chills sometimes with mild dyspnoea</span></p>\n</td>\n<td>\n<p><span>Antihistamines and antipyretics</span></p>\n<p><span>Transfusion can be stopped if symptoms are severe</span></p>\n<p>Prevention: Leukoreduced products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Transfusion-related acute lung injury (TRALI)</strong></span></p>\n<p><span>(1-6 hours)</span></p>\n</td>\n<td>\n<p><span>Anti-HLA type 2 antibodies in donor plasma bind recipient WBCs, increase capillary permeability</span></p>\n</td>\n<td>\n<p><span>Hypoxia, non-cardiogenic pulmonary edema</span></p>\n<p><span>CXR: Bilateral interstitial infiltrates</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately</span></p>\n<p><span>Supportive care</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Acute hemolytic transfusion reaction</strong></span></p>\n<p><span>(during transfusion to within 24h)</span></p>\n</td>\n<td>\n<p><span>ABO incompatibility</span></p>\n<p><span>(Type 2 hypersensitivity)</span></p>\n<p><span>Pre-existing high affinity IgM antibodies rapidly induce complement mediated lysis, intra-vascular hemolysis, and hemoglobinuria</span></p>\n</td>\n<td>\n<p><span>Fever, chills, flank/back pain</span></p>\n<p><span>Sense of impending doom</span></p>\n<p><span>Hemoglobinuria</span></p>\n<p><span>DIC, Renal failure</span></p>\n<p><span>Coomb&rsquo;s test positive, pink plasma</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delayed hemolytic transfusion reaction</strong></span></p>\n<p><span>occurs after 24 hours ( usually 2 weeks )</span></p>\n</td>\n<td>\n<p><span>Recipients have prior exposure to RBC antigens. </span><span>After the transfusion, anamnestic response results in antibody production</span></p>\n<p><span>Typically caused by IgG antibodies to foreign protein antigens and are associated with laboratory features of hemolysis.</span></p>\n</td>\n<td>\n<p><span>Mild fever, hemolytic anemia</span></p>\n<p><span>Coomb&rsquo;s test positive</span></p>\n<p><span>Screening for new antibodies positive</span></p>\n</td>\n<td>\n<p><span>Supportive care</span></p>\n<p><span>Additional transfusions if needed</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span><strong>Non-immune</strong> mediated transfusion reactions are as follows:</span></p>\n<ul>\n<li><span>Transfusion-associated circulatory overload (TACO)</span></li>\n<li><span>Hypothermia</span></li>\n<li><span>Electrolyte abnormality- hyperkalemia, hypocalcemia</span></li>\n<li><span>Iron overload</span></li>\n<li><span>Transient hypotension</span></li>\n<li><span>Immunomodulation</span></li>\n<li><span>Blood-borne infections&nbsp;</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7039",
      "difficulty": "medium"
    },
    {
      "text": "A patient with chronic kidney disease came with complaints of vomiting and diarrhea. His blood gas reports show pH = 7.40, HCO3- = 23 mEq/L, Na+ = 145 mEq/L, Cl- = 100 mEq/L. What is your probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "No acid base abnormality"
        },
        {
          "id": 2,
          "text": "Respiratory acidosis"
        },
        {
          "id": 3,
          "text": "Metabolic alkalosis"
        },
        {
          "id": 4,
          "text": "High anion gap metabolic acidosis with metabolic alkalosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The probable diagnosis is a&nbsp;high anion gap metabolic acidosis<strong> (HAGMA) </strong>with<strong> metabolic alkalosis</strong>.</p>\n<p>Interpretation of the ABG:</p>\n<p>Step 1: The pH being&nbsp;<strong>7.4</strong>&nbsp;is within normal limits.</p>\n<p>Step 2: Plasma HCO<sub>3</sub><sup>-</sup> is <strong>23 mEq/L</strong> and again is within normal limits.</p>\n<p>At this juncture, we have ruled out options B and C as this particular clinical scenario is not suggestive of a simple acid-base disorder.</p>\n<p>Step 3: Calculating the Anion gap:</p>\n<p>  Anion gap = [Na+] &ndash; ([Cl-] + [HCO3-])</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;= 145-(100+23)</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;= <strong>22 mEq/L</strong></p>\n<p>The presence of a high anion gap indicates that there's indeed an acid-base disorder, thus ruling out option A.</p>\n<p>A <strong>high anion gap </strong>indicates<strong> metabolic acidosis</strong>. However, HCO3- levels within normal limits suggest that there is also <strong>coexisting</strong> <strong>metabolic alkalosis</strong> in this patient.</p>\n<p>This can be confirmed by calculating the<strong>&nbsp;delta gap</strong>.</p>\n<p>Delta gap =&nbsp;<strong>&Delta;AG -&nbsp;&Delta;HCO<sub>3</sub><sup>-</sup></strong></p>\n<p>In this scenario: Delta gap = (22-10) - (24-23) = <strong>11</strong> <strong>mEq/L</strong></p>\n<p>Delta gap is &gt; +6 suggesting the presence of metabolic alkalosis along with HAGMA.</p>\n<p>If the delta gap is significantly <strong>positive (&gt;+6)</strong>,<strong> metabolic alkalosis</strong> is present because the rise in the anion gap is more than the fall in bicarbonate. If the delta gap is significantly <strong>negative (&lt;6)</strong> then <strong>hyperchloremic acidosis</strong> is usually present because a rise in the anion gap is less than a fall in bicarbonate.</p>\n<p>Alternatively, this can be confirmed by calculating the <strong>delta ratio</strong>.</p>\n<p>Delta ratio = the<strong> increase in Anion Gap / the decrease in HCO3-</strong></p>\n<p>It is used in the presence of a high anion gap metabolic acidosis (HAGMA), to check it is a &lsquo;pure&rsquo; HAGMA or if there is coexistant normal anion gap metabolic acidosis (NAGMA) or metabolic alkalosis.</p>\n<p>Delta ratio values:</p>\n<ul>\n<li>1-2 indicates HAGMA</li>\n<li>&lt; 1 indicates NAGMA + HAGMA</li>\n<li>&gt; 2 indicates HAGMA + Metabolic alkalosis</li>\n</ul>\n<p>In this scenario,</p>\n<p>Delta ratio = 12/1 = <strong>12</strong></p>\n<p>Thus, the acid-base disorder for the above scenario is <strong>HAGMA with metabolic alkalosis.</strong></p><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7038",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not done before drawing blood for arterial blood gas analysis?",
      "choices": [
        {
          "id": 1,
          "text": "Allen's test"
        },
        {
          "id": 2,
          "text": "Rinse syringe with heparin"
        },
        {
          "id": 3,
          "text": "Flexion of wrist"
        },
        {
          "id": 4,
          "text": "Placing needle at 45 degree angle"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Flexion<strong>&nbsp;</strong>of the wrist is not done just before drawing blood for ABG analysis.</p>\n<p>During <strong>arterial blood gas analysis</strong>, the ideal position for drawing arterial blood from the radial artery is to maintain the wrist in <strong>extension</strong>. This provides stability to the artery and prevents it from slipping away during the puncture. To draw blood for ABG analysis, the skin is pierced at a&nbsp;<strong>45&deg; angle</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ea86fa0647a9456bac259846ddc9dd57x1280x1474.JPEG\" alt=\"Explanation Image\"><p><strong>Allen's test</strong> is done prior to radial cannulation to&nbsp;identify the adequacy of radial and ulnar <strong>collateral</strong> blood flow to the hand.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59fa46e281d74732bbefef2cf5b70c5dx1280x3192.JPEG\" alt=\"Explanation Image\"><p>The syringe used to draw blood for ABG analysis is <strong>rinsed with heparin</strong> prior to the procedure.&nbsp;Prior to collecting blood, 0.1 ml heparin is drawn into the syringe and then flushed out. The residue that lubricates the inner wall of the syringe&nbsp;is sufficient to prevent the blood from clotting.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7037",
      "difficulty": "medium"
    },
    {
      "text": "Anti-nuclear antibodies are required for the diagnosis of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Scleroderma"
        },
        {
          "id": 2,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 4,
          "text": "Sjogren's syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Antinuclear antibodies (ANAs) </strong>are required for the diagnosis of <strong>systemic lupus erythematosus.&nbsp;</strong></p>\n<p>ANAs are autoantibodies that bind to the contents of the cell nucleus. They are present in &gt; 95% of patients with SLE. A positive antinuclear antibody ( ANA ) test with a titer of at least 1:80 is the obligatory entry criterion along with the additive criteria in 7 clinical and 3 immunologic domains. If a total of &gt;10 points achieved, it is indicative of SLE according to <strong>2019 EULAR/ACR Classification Criteria </strong>for Systemic Lupus Erythematosus (SLE)&nbsp;</p>\n<p>Most sensitive antibody for SLE: <strong>ANA</strong></p>\n<p>Most specific antibody for SLE: <strong>Anti smith</strong> &gt; Anti dsDNA&nbsp;<br />ANA may also be positive in the other options but it is not a criterion for diagnosis of these conditions.</p>\n<p>The following antibodies are specific for their respective autoimmune conditions.&nbsp;</p>\n<ul>\n<li><strong>Scleroderma </strong>(option A)<strong>: Anti-topoisomerase I(Scl-70) </strong>and <strong>anti-centromere</strong> antibodies highly specific for Systemic sclerosis.</li>\n<li><strong>Rheumatoid arthritis</strong> (option C): <strong>RF</strong> and <strong>anti-CCP </strong>antibodies&nbsp;</li>\n<li><strong>Sjogren syndrome</strong> (option D): <strong>Anti-Ro, Anti-La&nbsp;</strong></li>\n</ul><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7035",
      "difficulty": "easy"
    },
    {
      "text": "An intern is asked to measure the blood pressure of a patient with cardiac tamponade. He/she should ask the patient to:",
      "choices": [
        {
          "id": 1,
          "text": "Hold breath"
        },
        {
          "id": 2,
          "text": "Take rapid shallow breaths"
        },
        {
          "id": 3,
          "text": "Take long deep breaths"
        },
        {
          "id": 4,
          "text": "Breathe normally"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient with<strong> cardiac tamponade</strong> is asked to breathe normally to elicit <strong>pulsus paradoxus.</strong></p>\n<p>In a patient with cardiac tamponade, both ventricles share an incompressible pericardial covering due to the fluid. As the right ventricle enlarges during inspiration, the interventricular septum bulges into the left ventricle, reducing the left ventricular volume.</p>\n<p>This results in <strong>reduced stroke volume</strong> and hence <strong>reduced systolic arterial pressure.&nbsp;</strong><br />As a result, there is a<strong> greater than normal (more than 10 mmHg)</strong> <strong>fall</strong> in <strong>systolic</strong> arterial blood pressure during inspiration, producing pulsus paradoxus.</p>\n<p>This cannot be elicited if the patient is holding his/her breath, taking long or shallow breaths.</p>\n<p>Pulsus paradoxus is also seen with<strong> effusive constrictive pericarditis, restrictive cardiomyopathy</strong> and <strong>right ventricular myocardial infarction.</strong></p><hr><h3>Related Pearl: Causes of Pulsus Paradoxus</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Physiological causes</p>\n</td>\n<td>\n<p>Obesity</p>\n<p>Pregnancy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular causes</p>\n</td>\n<td>\n<p>Cardiac tamponade &ndash; most common cause</p>\n<p>Constrictive pericarditis ( in 1/3<sup>rd</sup> cases )</p>\n<p>Massive pulmonary embolism</p>\n<p>Severe CCF</p>\n<p>Hypovolemic shock</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Respiratory causes</p>\n</td>\n<td>\n<p>Severe obstructive lung disease</p>\n<p>Acute severe asthma</p>\n<p>Severe emphysema</p>\n<p>Tension pneumothorax</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7036",
      "difficulty": "medium"
    },
    {
      "text": "In the sagittal section of the brain given below if the coloured area is affected, which of the following is not seen?",
      "choices": [
        {
          "id": 1,
          "text": "Urinary incontinence"
        },
        {
          "id": 2,
          "text": "Gait abnormality"
        },
        {
          "id": 3,
          "text": "Perianal anesthesia"
        },
        {
          "id": 4,
          "text": "Fecal incontinence"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Paracentral lobule (PCL)</strong> is the continuation of the <strong>precentral</strong> and <strong>postcentral</strong> <strong>gyri</strong> of the superolateral surface into the medial surface of cerebral hemisphere. It controls the motor and sensory innervations of the contralateral lower extremity. It is also responsible for cortical control of micturition and defecation.</p>\n<p>The anterior two-thirds of PCL belong to <strong>Brodmann area 4,</strong> it reflects the primary motor cortex for the muscles of contralateral leg, foot, and perineum,it is functionally important in control of bladder and anal sphincters. Therefore, it's called the cortical center of defecation and micturition.</p>\n<p>The posterior third of the PCL contains 3,2 and 1, it reflects the primary somatosensory representation of the leg and foot.</p>\n<p>The <strong>A2 segment</strong> of the <strong>anterior cerebral artery</strong> supplies the <strong>paracentral lobule. </strong>Lesions in the paracentral lobule lead to:</p>\n<ul>\n<li>Weakness and loss of sensation in contralateral lower limb</li>\n<li>Urinary incontinence</li>\n<li>Fecal incontinence.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/db04684e345449d1b3e3bcaf0e79f7df.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7032",
      "difficulty": "hard"
    },
    {
      "text": "A hypertensive patient is on metoprolol. If verapamil is added, there is a risk of:",
      "choices": [
        {
          "id": 1,
          "text": "Atrial fibrillation"
        },
        {
          "id": 2,
          "text": "Bradycardia with AV block"
        },
        {
          "id": 3,
          "text": "Tachycardia"
        },
        {
          "id": 4,
          "text": "Torsades de pointes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Metoprolol, when added with verapamil, leads to <strong>bradycardia with AV block.</strong></p>\n<p>Verapamil and &beta; blockers have additive effect on inhibiting SA node and AV conduction,&nbsp;and the combination should be avoided to prevent severe bradycardia and conduction block.</p>\n<p>These agents can also have additive effect on decreasing left ventricular function which could seriously impair cardiac output in a patient with heart failure.</p><hr><h3>Related Pearl: European society of cardiology guidelines for treatment of hypertension</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Indication</strong></p>\n</td>\n<td>\n<p><strong>Initial treatment of choice&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertension alone or hypertension with diabetes/ cerebrovascular disease</p>\n</td>\n<td>\n<p>ACEi/ARB + CCB/diuretic (A+C or A+D)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertension with coronary artery disease</p>\n</td>\n<td>\n<p>ACEi/ ARB + beta blocker/CCB (A+B or A+C)</p>\n<p>or</p>\n<p>beta-blocker + diuretic (B+D)</p>\n<p>or&nbsp;</p>\n<p>CCB+ diuretic/ beta-blocker (C+B or C+D)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertension with chronic kidney disease</p>\n</td>\n<td>\n<p>ACEi/ARB + CCB/diuretic (A+C or A+D)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypertension with heart failure and reduced ejection fraction</p>\n</td>\n<td>\n<p>ACEI/ ARB + diuretic + beta-blocker (A+D+B)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pregnancy</p>\n</td>\n<td>\n<p>Labetalol, Nifedipine, methyldopa</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACEi &ndash; Angiotensin-converting enzyme inhibitors</p>\n<p>ARB &ndash; Angiotensin II receptor blockers</p>\n<p>CCB &ndash; Calcium Channel Blockers</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7034",
      "difficulty": "easy"
    }
  ]
}